[wpml_language_selector_widget]

FAQs

DEEs are a group of rare and severe seizure disorders. They are associated with frequent seizures of varying types and intellectual disability—often coupled with significant developmental delay.

Most DEEs commonly begin in infancy or childhood (but may also first occur in adults). These children often have frequent and severe seizures of a variety of types. Typically, DEEs begin during early infantile or childhood periods, although any age group inclusive of adults can be affected.

There are a variety of kinds of DEES. Some of these include:

  • Lennox-Gastaut Syndrome
  • Dravet Syndrome
  • Tuberous Sclerosis Complex
  • Epilepsy of Infancy with Migrating Focal Seizures (EIMFS)
  • Infantile Spasms Syndrome (ISS)
  • Gelastic Seizures with Hypothalamic Hamartoma
  • Myoclonic-Atonic Epilepsy
  • Lafora Disease
  • Several Etiology-Specific Syndromes (eg, KCNQ2, CDKL5, PCDH19, etc)

A seizure is an event in a condition called epilepsy. Epilepsy is a brain disorder in which a person has two or more seizures that occur more than 24 hours apart. A seizure is a surge of electrical activity in the brain that can lead to a variety of symptoms, depending on which part of the brain is affected.1

Most patients with DEEs are now recognized as having some kind of genetic variant that causes their seizures. In one study of patients with diagnosed DEEs, nearly one third had genetic alterations in known or novel genes. As a result, an increasing number of genetic variants and mutations are associated with an increased risk of developing a DEE condition.1

Causes of DEEs can include a variety of problems in the body, including:

  • Structural Problems: Tuberous Sclerosis Complex, Hypothalamic Hamartomas, Hemimegalencephaly
  • Metabolic Deficiencies: Pyridoxine or Biotinidase Deficiency, GLUT1 Deficiency
  • Immune Disorders: Rasmussen Syndrome

Diagnosing the cause and specific type of DEE can help determine the best treatment. Treatment and management options for DEEs may include2:

  • Anti-seizure medication
  • Newer therapies (eg, cannabidiol, vigabatrin, ganaxolone, etc)
  • Surgical treatment
  • Dietary management (eg, ketogenic diet)
  • Occupational therapy, physiotherapy, speech therapy, and other allied health methods
  • Managing triggers and risks

In most cases, medications or other interventions are used to control the frequency and severity of seizures, and do not change the baseline level of functioning. However, reducing the seizure burden can lead to an improvement in quality of life. Sometimes when it appears seizures are controlled, breakthrough seizure activity can occur, and when this happens, more aggressive seizure treatment is needed.

References

  1. Epilepsy Foundation. Developmental and Epileptic Encephalopathy (DEE). Accessed August 20, 2024. https://www.epilepsy.com/what-is-epilepsy/syndromes/developmental-and-epileptic-encephalopathy
  2. Raga S, Specchio N, Rheims S, Wilmshurst JM. Developmental and epileptic encephalopathies: recognition and approaches to care. Epileptic Disord. 2021;23:40-52. doi:10.1684/epd.2021.1244

Pin It on Pinterest

Scroll to Top

You are now leaving the THRIVE site

The THRIVE Neuroscience Community of Care site is funded by an independent medical education grant from Jazz Pharmaceuticals. The following site is not affiliated with the THRIVE educational initiative and MLG is not responsible for its content.

For optimized Clinical Trial Tracker use, please utilize Chrome or Firefox browsers